Authors



Andrew Merker, PharmD

Latest:

HIV Infection: The Future of Therapy

Approximately 35 million individuals are currently living with HIV/AIDS.


G. Caleb Alexander, MD, FACP

Latest:

Impact of HIE Drug Formularies on Patient Out-of-Pocket Costs

Benefit structure and formulary design characteristics are important for individuals with high out-of-pocket costs in federally facilitated Health Insurance Exchanges.


Jim Jorgenson, RPh, MS

Latest:

Staging Colon Cancer: New Directions and Managed Care Implications

In September 2009, the Pharmacy & Therapeutics Society gathered a study group of 12 managed care medical and pharmacy directors. The objective was to examine the impact that biomarker-based assays could have on the approaches payers and providers use to manage cancer.


Marile L. Santamarina, PharmD, MS

Latest:

Diabetes and Depression: Knowing the Signs, Improving Outcomes

Pharmacists should encourage patients to recognize and report any symptoms of depression in order to achieve optimal control of diabetes.


Julio Vazquez, MS, PharmD

Latest:

Daily Dose and Costs of Therapy With Topical Testosterone Agents

We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.


Davy James

Latest:

Novel Drug Treats Allergic Asthma Without Inhibiting Flu Defenses

Inhibiting the calcium release-activated calcium channel found to be an effective approach to limit allergic asthma without affecting the body’s defenses against influenza.


Jeffery Fudin, PHARMD, DAIPM, FCCP, FASHP, FFSMB

Latest:

Carefully Assess Opioid Drug Interaction Risks

A CMS guide to the new medicare part D overutilization policies has takeaways for pharmacists.


Denise Swiatek, BS, PharmD

Latest:

Not Just Dispensing: The Unique Role of Pharmacists in an Outpatient Research Pharmacy

Pharmacists can serve as essential members of a research team in a role that involves much more than traditional dispensing functions.


Canyon Hopkins, PharmD Candidate

Latest:

Acute Coronary Syndrome Is a Medical Emergency

Pharmacists should identify barriers that may prevent patients from adhering to complicated regimens or receiving proper care.



Jill Schachte, RPh, MSPBA Candidate

Latest:

How to Create an Engaging Specialty Pharmacy Clinical Program

Effective clinical programs in specialty pharmacy encourage adherence and lead to superior treatment outcomes.



Casandra A. Holveck, 2018 PharmD Candidate, the University of Connecticut

Latest:

Persistence Patterns Post Insulin Initiation in Diabetes

The number of patients who have from diabetes is expected to almost double from 285 million to 438 million people by 2030 due to obesity trends.


Erica Krantz, PharmD Candidate

Latest:

"Right to Try" Legislation: A Developing Legal Issue Related to Medications

Individuals working in a health care field are often expected to have up-to-date information about the latest trends in laws and legislative changes related to their specialty.




Thomas L. Lenz, PharmD, MA, PAPHS

Latest:

Controlling Diabetes: Teaching Patients to Take Charge

The American Diabetes Association recommends that health care providers incorporate an estimated average glucose measurement when counseling patients with diabetes.


Cheng Wang, MD, PhD

Latest:

Predictors of Healthcare Costs After Initiating Dabigatran Versus Warfarin

The study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.


Kenenth C. Hohmeier, PharmD

Latest:

Understanding the Beers Criteria Is Essential

This medication list helps screen for and assess potentially inappropriate drugs to prevent adverse effects, hospitalization, and even death.


Marcy B. Bolster, MD

Latest:

Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis

Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.


Melissa Belli, PharmD, BCACP

Latest:

Increasing Vaccination Rates to Decrease Death Rates

Pharmacists were inducted into the world of immunizations about 20 years ago when they were first authorized to administer vaccines, making immunizations more accessible.


Richard J. Bruzek, PharmD

Latest:

Barriers to and Facilitators of Medication Adherence

This study reports on barriers to and facilitators of medication adherence for asthma and diabetes patients who were both adherent and nonadherent to their medication regimen.


Karley Tranchina, PharmD

Latest:

Telepharmacy Offers Opportunity Amid Pandemic

The contributions to patient care through the incorporation of digital clinical pharmacotherapy will help legitimize the role of pharmacists in telehealth.


Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP

Latest:

Closing Thoughts From The Panel On Pneumococcal Vaccination

The panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.


Colby L. Wilkinson, BA

Latest:

Variation in the Coverage of Disease-Modifying Multiple Sclerosis Drugs Among US Payers

An examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.



Ashley Mains Espinosa, PharmD, MS, CPHIMS

Latest:

340B Recertification: Annual Opportunity to Ensure 340B Program Compliance

The 340B Drug Pricing Program requires covered entities to ensure program integrity through several processes.


Janice L. Pringle, PhD

Latest:

Applying Value-Based Incentive Models Within Community Pharmacy Practice

Healthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.